1.44
+0.04(+2.86%)
Currency In USD
| Previous Close | 1.4 |
| Open | 1.43 |
| Day High | 1.47 |
| Day Low | 1.41 |
| 52-Week High | 1.9 |
| 52-Week Low | 0.52 |
| Volume | 1.32M |
| Average Volume | 4.4M |
| Market Cap | 449.74M |
| PE | -6.55 |
| EPS | -0.22 |
| Moving Average 50 Days | 1.36 |
| Moving Average 200 Days | 1.08 |
| Change | 0.04 |
If you invested $1000 in Ocugen, Inc. (OCGN) 10 years ago, it would be worth $7.87 as of December 25, 2025 at a share price of $1.44. Whereas If you bought $1000 worth of Ocugen, Inc. (OCGN) shares 5 years ago, it would be worth $640 as of December 25, 2025 at a share price of $1.44.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Ocugen CEO to Present at NobleCon21—Noble Capital Markets’ Twenty-First Annual Emerging Growth Equity Conference
GlobeNewswire Inc.
Nov 20, 2025 12:02 PM GMT
MALVERN, Pa., Nov. 20, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that Dr. Shankar Musunuri, Chairman, CEO, and Co-founde
Ocugen to Host Webcast on Wednesday, November 5 at 8:30 A.M. ET to Discuss Business Updates and Third Quarter 2025 Financial Results
GlobeNewswire Inc.
Oct 23, 2025 11:30 AM GMT
MALVERN, Pa., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that it will host a conference call and live webcas
Ocugen to Present at Industry and Investor Conferences in October 2025
GlobeNewswire Inc.
Oct 02, 2025 11:30 AM GMT
MALVERN, Pa., Oct. 02, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced that executive leadership will present at the 2025